Related Experiment Video

Updated: Jun 1, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Phase 0 clinical trials will overcome stagnation of anticancer drug development?

L Mendoza1

  • 1INC Research, Prague, Czech Republic. Lmendoza@incresearch.com

Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|June 7, 2011
PubMed

Insights

Phase 0 clinical trials, a new approach for anticancer drug development, offer early insights into drug effects and biomarkers. Despite controversy over patient benefit, these trials are crucial for advancing targeted cancer therapies.

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Drug Development

Background:

  • The US Food and Drug Administration now supports exploratory Phase 0 clinical trials for novel anticancer agents.
  • Phase 0 trials are controversial due to the absence of direct clinical benefit for patients.
  • These trials represent a shift towards earlier human testing in drug development.

Purpose of the Study:

  • To explore the utility of Phase 0 clinical trials in the development of innovative anticancer agents, particularly targeted therapies.
  • To highlight the potential of Phase 0 trials in providing early biological and pharmacokinetic data.
  • To discuss the role of Phase 0 trials in assessing drug effects and biomarkers in human tumoral samples.

Main Methods:

  • Utilizing Phase 0 exploratory clinical trials.
  • Focusing on the assessment of biological effects on tumoral targets.
  • Evaluating drug effect biomarkers and generating human pharmacokinetic/pharmacodynamic data.

Main Results:

  • Phase 0 trials provide a platform for assessing target engagement in human tumors.
  • Biomarkers for drug effects can be evaluated early in the development process.
  • Essential human pharmacokinetics and pharmacodynamics data can be generated sooner.

Conclusions:

  • Phase 0 clinical trials are valuable for early assessment of anticancer agents.
  • These trials facilitate earlier understanding of drug behavior in humans.
  • Phase 0 trials are anticipated to become standard in early-phase oncological drug development.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue07:31

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

Published on: May 26, 2023

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...